De omzetaandelen zijn schattingen voor three months ended July 31, 2026, geen cijfers uit een ingediend rapport.
Heart rhythm and ablation devices
Pacemakers, defibrillators, heart-monitoring devices, and catheters used to treat or monitor irregular heart rhythms. Named products include Micra pacemakers, Reveal LINQ monitors, PulseSelect catheters, and the Affera mapping and ablation system.
Heart valve and vascular products
Evolut devices replace a narrowed aortic valve through a catheter procedure. Medtronic also sells surgical heart valves, stent grafts for aortic disease, coronary stents, and balloons used in blood-vessel procedures.
Spine and neurosurgery products
Spine implants treat conditions such as spinal deformity and damaged discs. StealthStation provides navigation during surgery, O-arm provides operating-room imaging, and Mazor systems guide robotic-assisted spine procedures.
Neurological stimulation and stroke devices
InterStim devices stimulate nerves to treat bladder and bowel conditions; Inceptiv and Percept devices provide spinal or brain stimulation for certain conditions. Pipeline devices treat some brain aneurysms, and Solitaire devices are used in procedures for certain strokes.
Surgical and endoscopy products
Endo GIA staplers and LigaSure instruments are used during surgery; Hugo assists surgeons in certain procedures. PillCam cameras are swallowed to capture images inside the digestive tract, and GI Genius helps examine colonoscopy images.
Patient monitoring and airway products
Nellcor monitors measure blood oxygen, McGRATH MAC devices help clinicians place breathing tubes, and Shiley tubes help maintain a patient’s airway.
Medtronic designs, makes, and sells medical devices and related services to healthcare systems, clinicians, and patients in more than 150 countries. Its products include implanted heart devices, surgical tools, spine implants, equipment for monitoring patients, and therapies that use electrical stimulation to treat certain conditions. Its Diabetes Business became a separately listed company, MiniMed, through an initial public offering in March 2026, but its sales were still included in Medtronic’s July 2026 quarterly results.
Gebouwd uit de eigen deponeringen van Medtronic plc bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.
The themes Medtronic is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
US$ 102,86+1,8%slot 13 nov
Volgende cijfers: 24 november 2026 · vóór de opening
Cijfers tot en met 31 juli 2026, uit de 10-Q ingediend op 3 september 2026
Medtronic makes medical devices and therapies used to treat heart, brain, spine, surgical, and other health conditions.
Grade A+
De balk onder de koers toont het cijfer op elke datum, alleen gebaseerd op de stukken die toen al openbaar waren.
Toont 2 van 40 kwartalen van de cijferhistorie van Medtronic plc. De andere 38 lopen terug tot december 2016.
